The HCPLive Gastroenterology condition center page is a comprehensive resource for clinical news and insights on digestive and GI conditions. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for C difficile, IBS and IBD, Crohn's disease, and more.
November 22nd 2024
The supplemental Biologics License Application is supported by the phase 3 ASTRO study of guselkumab SC induction therapy in ulcerative colitis.
Hepatitis C Behind Bars May Be Too Costly to Cure
April 16th 2015A study of Rhode Island state prisons shines a spotlight on the trouble correctional facilities face because they aren't financially equipped to bear the budget-busting costs of new drugs to treat all inmates chronically infected with hepatitis C.
Could Man's Best Friend Spread Norovirus?
Norovirus, the leading cause of acute gastroenteritis in adults and children in the US (aka "stomach flu" marked by vomiting and diarrhea) could potentially be spread from canines to humans, according to research published in the Journal of Clinical Microbiology.
TORe Procedure Blazes New Path for Gastric Bypass Patients Part 4
While TORe has been a significant development in the treatment of overweight and obese patients who have undergone gastric bypass surgery there are more procedures on the horizon that could provide even greater benefits in the future.
TORe Procedure Blazes New Path for Gastric Bypass Patients Part 3
Even more so than gastric bypass surgery, the work of the patient determines how effective TORe can be in helping them keep from re-gaining excess weight. With diet, exercise, and working with their healthcare professionals the results can be positive for everyone involved.
TORe Procedure Blazes New Path for Gastric Bypass Patients Part 2
While gastric bypass has provided benefits for millions of patients it has not been without its share of complications and difficulties after the procedure. Over the past few years work has been done to find ways to help patients after undergoing the original operation.
TORe Procedure Blazes New Path for Gastric Bypass Patients
Across the country millions of people have undergone gastric bypass surgery in an effort to lose weight and improve their overall health. For those patients who have seen their results diminish a relatively new procedure could get them back on the road to a healthy lifestyle.
Over-the-Counter Allergy Drug Treats Hepatitis C As Well As Antivirals
April 8th 2015How could an effective, inexpensive hepatitis C virus (HCV) drug have been available at local pharmacies without clinicians and patients knowing it? Researchers from the National Institutes of Health (NIH) have the answer.
Swiss Company Offers Test for Gut Inflammation Patients Can Administer at Home
Bühlmann, a global calprotectin laboratory headquartered in Switzerland, announced Wednesday the launch of IBDoc®, the first at home in-vitro diagnostic test to measure the fecal inflammation marker calprotectin in patients with inflammatory bowel disease (IBD), Crohn's disease (CD), and Ulcerative colitis (UC).
Obesity: A 'Super-size" Problem
April 8th 2015Although the obesity epidemic in the United States seems to have reached a plateau over the past few years, the prevalence of obesity continues to be high with 30% of Americans classified as obese, defined as having a BMI of 30 kg/m2 or more, and an additional 30% overweight, with a BMI of 25 to 29.9 kg/m2.
Gut Micriobiome and Its Role in Allergy and Asthma
One of the hottest topics in medical science today is the role of the gut microbiome and its affect on various aspects of a person's health. A recent study looked at whether it can help predict the likelihood of a child having health issues linked to allergy and asthma.
New Prescriptions, Costs Present Challenges for Allergists Part 2
There seems to be an ever growing list of items people are allergic to, and allergies that would only last a matter of months now stretch throughout the calendar for many. How best to handle these patients has become a focal point of care for allergists.
Non-alcoholic steatohepatitis (NASH), deemed a more serious form of non-alcoholic fatty liver disease (NAFLD) that can develop into liver fibrosis and cirrhosis, has been linked to the liver cancer-spiraling leaky intestinal wall, according to research in Cellular and Molecular Gastroenterology and Hepatology.
Delay in Growth Spurs Pediatric IBD Onset
Symptoms of delayed growth, weight loss, failure to gain weight, or persistent stomach pain coupled with diarrhea or bloody stools in children are often linked to undiagnosed inflammatory bowel disease (IBD), particularly Crohn's disease (CD).
FDA Warns of Serious Slowing of Heart Rate with Hepatitis C Drugs and Amiodarone
March 28th 2015The FDA approved label warning changes for two Gilead Sciences hepatitis C drugs after one person died and nine others had serious reactions when the drugs were coadministered with amiodarone, a drug used to treat irregular heartbeat.